Hillrom and Welch Allyn are a part of Baxter.
BREVIBLOC Injection (Esmolol Hydrochloride) 2,500 mg/250 mL in INTRAVIA Plastic Container
Item Number: 1001905561
GTIN:
00310019055619
GTIN-CS:
50310019055614
Added to Your Cart
Product Availability by Store Location
Hours
BREVIBLOC Premixed Injection (Esmolol Hydrochloride) 2,500 mg/250 mL (10 mg/mL) Ready-to-use-Bags in INTRAVIA Plastic Container. Liquid Premix. NDC 10019-0055-61
Product Characteristics
| Trademark | BREVIBLOC - Trademark of Baxter International Inc., its subsidiaries or affiliates. |
| Volume | 250.0 ml |
| Latex Free | Yes |
| Shelf Life from Manufacture | 24 Months |
| Concentration | 10 mg/mL |
| Container Type | INTRAVIA |
| Containes Preservative | No |
| Dosage Form | Liquid |
| Drug Class | Anti-Arrythmics |
| Polyethlene Lined | No |
| Rx Only | Yes |
| Storage Recommendations | Store at 25°C (77°F). Excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. Protect from freezing. Avoid excessive heat. |
| Strength | 2500 mg/250 mL |
Carton
| Units per Case | 10.0 |
| Carton Weight | 8.0 lb. |
| Carton Length | 13.38 in. |
| Carton Width | 13.38 in. |
| Carton Height | 5.5 in. |
| Carton Volume | 0.57 fc |
Reimbursement Information
| HCPCS Code | HCPCS Description |
| J1805 | Inj, esmolol hcl, 10mg |
| A4216 | STERILE WATER, SALINE AND/OR DEXTROSE, DILUENT/FLUSH, 10 ML |
| Medication Delivery Reimbursement Hotline | 888-338-0001 |
Information Source : CMS
Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
Disclaimer:The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies.
| Item Number | 1001905561 |
| Sales Unit | pack |
| GTIN | 00310019055619 |
| GTIN-CS | 50310019055614 |
| National Drug Code | 1001905561 |
Documentation
203052r1
Do you want to save the changes before you leave?
We are processing your request, do not go back, refresh or close the window.
Please wait...
Please wait...


